Youchao J. Jia

Chinese PLA General Hospital 28 Fuxing Road
Haidian, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Evaluation of the efficacy and safety of first-line therapies for peripheral T-cell lymphoma: a systematic review and network meta-analysis.

Evaluation of the efficacy and safety of first-line therapies for peripheral T-cell lymphoma: a systematic review and network meta-analysis.

Journal: Frontiers in oncology

Published: June 18, 2026

Anti-PD-1 monoclonal antibody combined with chemotherapy for porocarcinoma: a case report and literature review.

Anti-PD-1 monoclonal antibody combined with chemotherapy for porocarcinoma: a case report and literature review.

Journal: Frontiers in oncology

Published: January 19, 2026

Author Correction: Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.

Author Correction: Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.

Journal: Nature biomedical engineering

Published: September 22, 2025

Single cell profiling reveals malignant states and immune landscapes in PCNSL and systemic DLBCL.

Single cell profiling reveals malignant states and immune landscapes in PCNSL and systemic DLBCL.

Journal: iScience

Published: August 11, 2025

Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study.

Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study.

Journal: MedScience

Published: August 06, 2025

Combination of artesunate and ruxolitinib suppresses T cell leukemia/lymphoma proliferation via the JAK STAT pathway.

Combination of artesunate and ruxolitinib suppresses T cell leukemia/lymphoma proliferation via the JAK STAT pathway.

Journal: Scientific reports

Published: July 29, 2025

Epigenetic remodeling and apoptotic activation by Chidamide suppress small cell lung cancer in molecularly distinct subtypes.

Epigenetic remodeling and apoptotic activation by Chidamide suppress small cell lung cancer in molecularly distinct subtypes.

Journal: Discover oncology

Published: April 21, 2025

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Journal: Research square

Published: January 27, 2025

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Journal: Blood cancer journal

Published: January 24, 2025

Comparative safety of different first-line treatments for chronic lymphocytic leukemia/small lymphocytic lymphoma: A systematic review and network meta-analysis.

Comparative safety of different first-line treatments for chronic lymphocytic leukemia/small lymphocytic lymphoma: A systematic review and network meta-analysis.

Journal: Annals of hematology

Published: July 08, 2024

Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma.

Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma.

Journal: Journal of the National Cancer Center

Published: October 13, 2023

Cullin7 induces docetaxel resistance by regulating the protein level of the antiapoptotic protein Survivin in lung adenocarcinoma cells.

Cullin7 induces docetaxel resistance by regulating the protein level of the antiapoptotic protein Survivin in lung adenocarcinoma cells.

Journal: Journal of thoracic disease

Published: July 17, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026